Matinas BioPharma is a clinical stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum therapeutics for the treatment of serious and life threatening infections. The Company s proprietary, disruptive technology utilizes lipid crystal nano particle cochleates to nano encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable. The Company s lead drug candidate is MAT , an orally administered, encochleated formulation of amphotericin B a broad spectrum fungicidal agent . The Company has an open Investigational New Drug IND application for MAT , which is an orally administered, encochleated formulation of amikacin a broad spectrum aminoglycoside antibiotic agent for acute bacterial infections, including non tuberculous mycobacterium NTM and multi drug resistant gram negative bacterial infections. For more information, please visit www.matinasbiopharma.com lt / td gt
Quote | Matinas Biopharma Holdings Inc. (NYSE:MTNB)
Last: | $0.1602 |
---|---|
Change Percent: | 0.0% |
Open: | $0.1589 |
Close: | $0.1602 |
High: | $0.1608 |
Low: | $0.1576 |
Volume: | 752,393 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Matinas Biopharma Holdings Inc. (NYSE:MTNB)
BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces the recent successful...
BEDMINSTER, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that MAT2203, its ora...
Message Board Posts | Matinas Biopharma Holdings Inc. (NYSE:MTNB)
Subject | By | Source | When |
---|---|---|---|
Lets go go go go... Up up and away we go. | dhbuzz | investorshub | 05/08/2023 6:16:46 PM |
news all the way baby | dhbuzz | investorshub | 05/06/2023 3:00:33 PM |
$MTNB bears and bulls | RealFooFighters | investorshub | 05/05/2023 6:39:58 AM |
MomentumIts trading | RealFooFighters | investorshub | 05/02/2023 8:01:29 AM |
best news of the day | The Lawman | investorshub | 05/01/2023 2:25:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Matinas Biopharma Holdings Inc. Company Name:
MTNB Stock Symbol:
NYSE Market:
Matinas Biopharma Holdings Inc. Website:
BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces the recent successful...
BEDMINSTER, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that MAT2203, its ora...
BEDMINSTER, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces new in vitro data ...